Eli Lilly is the best of both worlds — a recession-resistant stock with major growth potential
The year ahead is pivotal for Eli Lilly (LLY) as the pharmaceutical giant advances its stellar drug pipeline.
Source link
The year ahead is pivotal for Eli Lilly (LLY) as the pharmaceutical giant advances its stellar drug pipeline.
Source link